A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial
Dermatologic Therapy May 20, 2021
Spada F, Harrison IP, Barnes TM, et al. - Researchers conducted this randomized, double-blind, placebo-controlled, single centre, comparative trial to determine whether a two‐part system consisting of a ceramide‐dominant physiological lipid‐based moisturizing cream and cleanser could ameliorate the signs and symptoms of moderate eczema in adult patients compared with placebo over 28 days. Assessments were performed at baseline and every 7 days thereafter. There were no patients who dropped out of the study due to adverse events (AEs), and there were no serious AEs. Adults with eczema can benefit from a ceramide‐dominant moisturizing cream and cleanser that restores skin permeability and alleviates eczema symptoms.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries